COVID-19 Antibodies Among Healthcare Workers

Completed

• Conditions: SARS-CoV 2; COVID-19

• Registration Number: NCT04425889
• Lead Sponsor: Hospital Universitario Dr. Jose E. Gonzalez

Brief Summary

Observational, point of prevalence study determining the presence of anti-SARS-CoV-2 antibody

Detailed Description

All Healthcare workers (HCW) who had entered contaminated areas at least once and that 14 days or more had passed from their first entrance to contaminated areas were included. They were classified as asymptomatic and pauci-symptomatic. A COVID-19 IgG/IgM rapid test was used for antibody detection, and selected participants were subject to real time polymerase chain reaction (qPCR) for SARS-CoV-2.

Study Timeline

• Study Start: 2020-05-05
• Primary Completion: 2020-05-30
• Status Verified: 2020-06
• Study Completion: 2020-06-01
• Study First Submitted: 2020-06-06
• Study First Submitted QC: 2020-06-09
• Last Update Submitted: 2020-06-10
• Study First Posted: 2020-06-11
• Last Update Posted: 2020-06-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 156

Inclusion Criteria

• All healthcare workers who had entered contaminated areas at least once and that 14 days or more had passed from their first entrance were included

Exclusion Criteria

• Healthcare workers who did not have exposure for more or equal 14 days
• Healthcare workers who did not wish to participate

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Presence of antibody	through study completion, an average of 8 weeks	presence of IgG and/or IgM against SARS-CoV-2

Trial Locations

Locations (1)

Hospital Universitario José E. Gonzalez; 🇲🇽 Monterrey, Nuevo Leon, Mexico